Charles River Laboratories

The application of digital twins to biotechnology requires modeling of biological entities, an emerging use case in drug discovery and development. Julia Schuler, PhD, discusses more with GEN. https://okt.to/NKRi8m

Since 2015, we've connected with a small group of women from Charles River who put a face like no other on what it's like to live with cancer. This year, our heroic group of women meet for the 10th and last time to share stories of hope and unexpected challenges. #breastcancer #LIFEatCRL https://okt.to/S2gXAf

Featured in GEN: The Urgent Need for Therapeutic Options in Rare Disease: https://okt.to/5ePmS4 Highlighting the critical missions driving Elly’s Team and FOXG1 Research Foundation, we are proud to be working hand-in-hand to develop and manufacture promising advanced therapies for rare diseases. Learn more from Michelle Krueger, Nasha Fitter, and Matthew Hewitt in this month’s issue of Genetic Engineering & Biotechnology News. #cellandgenetherapies #CGT #genetherapy #raredisease

Don’t miss this unique opportunity to engage directly with an expert in early in vivo integrated #toxicology.? Save your spot for this exclusive in-person presentation in Cambridge, Massachusetts. https://okt.to/2ampqs

Whether you are moving your cell therapy into clinical trials or preparing for commercial launch, there are several development, regulatory, and manufacturing roadblocks to avoid that can cause untimely delays. After passing audits for multiple commercial products by regulatory agencies in North America and Europe, learn how our expertise coupled with the proper facility capacity can support your program. Partner with a CDMO you can depend on. https://okt.to/hoaHfY #celltherapymanufacturing #cdmo #cgt

Your individual drug development needs are important, and your drug’s journey requires a customized approach. Learn how our investment in your success translates to a collaborative experience. https://okt.to/zEebVi

Getting your study data as quickly as possible is essential to maintain momentum and move your IND program forward. Our #Kansas facility provides data as real-time as possible with Charles River’s Apollo?, so that you can make decisions swiftly and with confidence. https://okt.to/f59DGZ

Are you looking for guidance with #Endocrine Disruptor testing to meet ECHA requirements? We offer regulatory support and customized comprehensive testing solutions for your in vitro and in vivo needs. ASK OUR EXPERTS: https://okt.to/xhMzqA

Human iPSC-derived neurons and glial cells are a robust and reproducible alternative to primary cells for modelling neuronal connections and #neuroinflammatory processes. At #Neuroscience 2024, our scientists will be presenting several posts using iSPCs, including novel, complex models of #neuroinflammation involving multiple cell types. https://okt.to/jJ5NQs #SfN24

At Charles River, our mission of creating healthier lives extends to improving access to life-saving treatments for children with cancer and other rare diseases. As a supporter of the Emily Whitehead Foundation and a sponsor of its Believe Ball, we are committed to helping families find support and ultimately a cure. Learn more about our commitment to the development of novel cell and gene therapies aimed at improving the lives of our youngest patients. https://okt.to/weN3dU #cellandgenetherapies #CDMO #childhoodcancer #raredisease #activatethecure